SCHEMBL6390809

SCHEMBL6390809

CCCNc1cc(NC)c2c(c1N)C(=O)c1ccccc1C2=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY4 P51582 12/20 0.46
▸ GNG2 P59768 1/20 0.44
▸ GNB1 P62873 1/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ EGFR P00533 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ PABPC1 P11940 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ P2RY2 P41231 7/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ NSD2 O96028 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ BLM P54132 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ TOP2B Q02880 1/20 0.42
▸ CYP1A1 P04798 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29240053 0.84 GNG2 (0.44) P2RY4GNG2GNB1RAB9AEGFR
SCHEMBL14582002 0.83 POLB (0.56) RAB9AEGFRMAPTPABPC1MAPK1
SCHEMBL11671900 0.83 P2RY4 (0.47) P2RY4GNG2GNB1MAPTSMN1; SMN2
SCHEMBL27658039 0.83 MAPT (0.43) P2RY4GNG2GNB1RAB9AEGFR
SCHEMBL27516756 0.80 P2RY4 (0.49) P2RY4GNG2GNB1RAB9AEGFR
SCHEMBL11131632 0.79 POLB (0.63) P2RY4RAB9AEGFRMAPTPABPC1
SCHEMBL29940221 0.79 POLB (0.63) P2RY4RAB9AEGFRMAPTPABPC1
SCHEMBL3168294 0.79 MAPK1 (0.54) P2RY4RAB9AEGFRMAPTPABPC1
SCHEMBL4225484 0.77 ADORA2A (0.42) P2RY4GNG2GNB1RAB9AEGFR
SCHEMBL28287515 0.77 ADORA2A (0.58) P2RY4RAB9AEGFRMAPTPABPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050132507-A1 Tertiary p-phenylenediamines, dyes compositions, and dyeing processes L'OREAL S.A. (FR) 2005-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050132507-A1 Tertiary p-phenylenediamines, dyes compositions, and dyeing processes KRT18, CDC73, DSP P2RY4 2091/4885GNG2 4092/4885GNB1 4217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback